{"entity":{"type":"insider","cik":"0001468950","url":"/insider/0001468950","json_url":"/insider/0001468950.json","name":"Clal Biotechnology Industries Ltd.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":6,"first":"2010-09-13","last":"2020-03-25","span_basis":"filed_date"},"name_variants":[{"name":"Clal Biotechnology Industries Ltd.","source":"filing","n_filings":6,"first_seen":"2010-09-13","last_seen":"2020-03-25"}],"transactions":[{"id":3165802,"accession":"0001209191-20-021160","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-021160","line_url":"/filing/0001209191-20-021160#line-3","is_derivative":false,"issuer_cik":"0001326628","issuer_name":"Neon Therapeutics, Inc.","issuer_ticker":"NTGN","issuer_name_source":null,"issuer_url":"/issuer/0001326628","owner_cik":null,"owner_name":"ACCESS INDUSTRIES MANAGEMENT, LLC; Access Industries Holdings LLC; ACCESS INDUSTRIES, LLC; Clal Biotechnology Industries Ltd.; Blavatnik Len","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":117400.0,"shares_display":"117,400","price_per_share":2.2022,"price_display":"2.20","price_state":"stated","total_value":258538.28,"total_display":"258,538.28","shares_owned_after":1896176.0,"shares_owned_after_display":"1,896,176","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-24","filed_date":"2020-03-25","scope":"insider"},{"id":3165801,"accession":"0001209191-20-021160","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-021160","line_url":"/filing/0001209191-20-021160#line-2","is_derivative":false,"issuer_cik":"0001326628","issuer_name":"Neon Therapeutics, Inc.","issuer_ticker":"NTGN","issuer_name_source":null,"issuer_url":"/issuer/0001326628","owner_cik":null,"owner_name":"ACCESS INDUSTRIES MANAGEMENT, LLC; Access Industries Holdings LLC; ACCESS INDUSTRIES, LLC; Clal Biotechnology Industries Ltd.; Blavatnik Len","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":84286.0,"shares_display":"84,286","price_per_share":2.1923,"price_display":"2.19","price_state":"stated","total_value":184780.1978,"total_display":"184,780.20","shares_owned_after":856304.0,"shares_owned_after_display":"856,304","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-24","filed_date":"2020-03-25","scope":"insider"},{"id":3165798,"accession":"0001209191-20-021160","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-021160","line_url":"/filing/0001209191-20-021160#line-1","is_derivative":false,"issuer_cik":"0001326628","issuer_name":"Neon Therapeutics, Inc.","issuer_ticker":"NTGN","issuer_name_source":null,"issuer_url":"/issuer/0001326628","owner_cik":null,"owner_name":"ACCESS INDUSTRIES MANAGEMENT, LLC; Access Industries Holdings LLC; ACCESS INDUSTRIES, LLC; Clal Biotechnology Industries Ltd.; Blavatnik Len","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50358.0,"shares_display":"50,358","price_per_share":2.1741,"price_display":"2.17","price_state":"stated","total_value":109483.3278,"total_display":"109,483.33","shares_owned_after":940590.0,"shares_owned_after_display":"940,590","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-23","filed_date":"2020-03-25","scope":"insider"},{"id":2285574,"accession":"0001209191-20-020788","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-020788","line_url":"/filing/0001209191-20-020788#line-2","is_derivative":false,"issuer_cik":"0001326628","issuer_name":"Neon Therapeutics, Inc.","issuer_ticker":"NTGN","issuer_name_source":null,"issuer_url":"/issuer/0001326628","owner_cik":null,"owner_name":"ACCESS INDUSTRIES MANAGEMENT, LLC; Blavatnik Len; Clal Biotechnology Industries Ltd.; ACCESS INDUSTRIES, LLC; Access Industries Holdings LLC","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":84339.0,"shares_display":"84,339","price_per_share":2.2161,"price_display":"2.22","price_state":"stated","total_value":186903.6579,"total_display":"186,903.66","shares_owned_after":2013576.0,"shares_owned_after_display":"2,013,576","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-20","filed_date":"2020-03-23","scope":"insider"},{"id":2285570,"accession":"0001209191-20-020788","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-020788","line_url":"/filing/0001209191-20-020788#line-1","is_derivative":false,"issuer_cik":"0001326628","issuer_name":"Neon Therapeutics, Inc.","issuer_ticker":"NTGN","issuer_name_source":null,"issuer_url":"/issuer/0001326628","owner_cik":null,"owner_name":"ACCESS INDUSTRIES MANAGEMENT, LLC; Blavatnik Len; Clal Biotechnology Industries Ltd.; ACCESS INDUSTRIES, LLC; Access Industries Holdings LLC","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9050.0,"shares_display":"9,050","price_per_share":2.5149,"price_display":"2.51","price_state":"stated","total_value":22759.845,"total_display":"22,759.84","shares_owned_after":990948.0,"shares_owned_after_display":"990,948","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-19","filed_date":"2020-03-23","scope":"insider"},{"id":6605444,"accession":"0001209191-18-040738","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-040738","line_url":"/filing/0001209191-18-040738#line-4","is_derivative":false,"issuer_cik":"0001326628","issuer_name":"Neon Therapeutics, Inc.","issuer_ticker":"NTGN","issuer_name_source":null,"issuer_url":"/issuer/0001326628","owner_cik":null,"owner_name":"ACCESS INDUSTRIES MANAGEMENT, LLC; Access Industries Holdings LLC; ACCESS INDUSTRIES, LLC; Clal Biotechnology Industries Ltd.; Blavatnik Len","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":315000.0,"shares_display":"315,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":5040000.0,"total_display":"5,040,000.00","shares_owned_after":2097915.0,"shares_owned_after_display":"2,097,915","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-29","filed_date":"2018-07-03","scope":"insider"},{"id":2417272,"accession":"0001178913-12-002171","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001178913-12-002171","line_url":"/filing/0001178913-12-002171#line-2","is_derivative":false,"issuer_cik":"0001451980","issuer_name":"BIOCANCELL THERAPEUTICS INC.","issuer_ticker":"BICL","issuer_name_source":null,"issuer_url":"/issuer/0001451980","owner_cik":"0001468950","owner_name":"Clal Biotechnology Industries Ltd.","owner_url":"/insider/0001468950","role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10731726.0,"shares_display":"10,731,726","price_per_share":0.217,"price_display":"0.22","price_state":"stated","total_value":2328784.542,"total_display":"2,328,784.54","shares_owned_after":27323134.0,"shares_owned_after_display":"27,323,134","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-31","filed_date":"2012-08-07","scope":"insider"},{"id":2717297,"accession":"0001178913-12-000620","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001178913-12-000620","line_url":"/filing/0001178913-12-000620#line-2","is_derivative":false,"issuer_cik":"0000919593","issuer_name":"BIOCANCELL THERAPEUTICS INC.","issuer_ticker":"BICL","issuer_name_source":null,"issuer_url":"/issuer/0000919593","owner_cik":null,"owner_name":"CLAL INDUSTRIES & INVESTMENTS LTD; Bergman Shelly; Clal Biotechnology Industries Ltd.; IDB DEVELOPMENT CORP LTD; IDB HOLDING CORP LTD; Dankner Nochi; Livnat Avraham; Manor Ruth","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8199400.0,"shares_display":"8,199,400","price_per_share":0.26,"price_display":"0.26","price_state":"stated","total_value":2131844.0,"total_display":"2,131,844.00","shares_owned_after":12444237.0,"shares_owned_after_display":"12,444,237","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-24","filed_date":"2012-03-07","scope":"insider"},{"id":7383899,"accession":"0001178913-10-002410","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001178913-10-002410","line_url":"/filing/0001178913-10-002410#line-3","is_derivative":false,"issuer_cik":"0000919593","issuer_name":"BIOCANCELL THERAPEUTICS INC.","issuer_ticker":"BICL","issuer_name_source":null,"issuer_url":"/issuer/0000919593","owner_cik":null,"owner_name":"IDB HOLDING CORP LTD; Manor Ruth; CLAL INDUSTRIES & INVESTMENTS LTD; Bergman Shelly; Dankner Nochi; Livnat Avraham; IDB DEVELOPMENT CORP LTD; Clal Biotechnology Industries Ltd.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4228.0,"shares_display":"4,228","price_per_share":0.8842,"price_display":"0.88","price_state":"stated","total_value":3738.3976,"total_display":"3,738.40","shares_owned_after":3838445.0,"shares_owned_after_display":"3,838,445","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-15","filed_date":"2010-09-13","scope":"insider"},{"id":7383897,"accession":"0001178913-10-002410","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001178913-10-002410","line_url":"/filing/0001178913-10-002410#line-2","is_derivative":false,"issuer_cik":"0000919593","issuer_name":"BIOCANCELL THERAPEUTICS INC.","issuer_ticker":"BICL","issuer_name_source":null,"issuer_url":"/issuer/0000919593","owner_cik":null,"owner_name":"IDB HOLDING CORP LTD; Manor Ruth; CLAL INDUSTRIES & INVESTMENTS LTD; Bergman Shelly; Dankner Nochi; Livnat Avraham; IDB DEVELOPMENT CORP LTD; Clal Biotechnology Industries Ltd.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":0.8194,"price_display":"0.82","price_state":"stated","total_value":3277.6,"total_display":"3,277.60","shares_owned_after":3834445.0,"shares_owned_after_display":"3,834,445","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-15","filed_date":"2010-09-13","scope":"insider"},{"id":7383895,"accession":"0001178913-10-002410","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-10-002410","line_url":"/filing/0001178913-10-002410#line-1","is_derivative":false,"issuer_cik":"0000919593","issuer_name":"BIOCANCELL THERAPEUTICS INC.","issuer_ticker":"BICL","issuer_name_source":null,"issuer_url":"/issuer/0000919593","owner_cik":null,"owner_name":"IDB HOLDING CORP LTD; Manor Ruth; CLAL INDUSTRIES & INVESTMENTS LTD; Bergman Shelly; Dankner Nochi; Livnat Avraham; IDB DEVELOPMENT CORP LTD; Clal Biotechnology Industries Ltd.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":0.8484,"price_display":"0.85","price_state":"stated","total_value":4666.2,"total_display":"4,666.20","shares_owned_after":3842673.0,"shares_owned_after_display":"3,842,673","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-13","filed_date":"2010-09-13","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":1,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":1},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001694187","name":"Neon Therapeutics, Inc.","url":"/issuer/0001694187","role":"Other","n_filings":3,"first_seen":"2018-07-03","last_seen":"2020-03-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001451980","name":"BIOCANCELL THERAPEUTICS INC.","url":"/issuer/0001451980","role":"Ten percent owner","n_filings":3,"first_seen":"2010-09-13","last_seen":"2012-08-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001468950","retrieved_at":"2026-08-22T04:43:26+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}